HK1147092A1 - 二螺 -三氧雜環戊烷抗瘧藥 - Google Patents

二螺 -三氧雜環戊烷抗瘧藥

Info

Publication number
HK1147092A1
HK1147092A1 HK11101070.8A HK11101070A HK1147092A1 HK 1147092 A1 HK1147092 A1 HK 1147092A1 HK 11101070 A HK11101070 A HK 11101070A HK 1147092 A1 HK1147092 A1 HK 1147092A1
Authority
HK
Hong Kong
Prior art keywords
dispiro
trioxolane antimalarials
trioxolane
antimalarials
Prior art date
Application number
HK11101070.8A
Other languages
English (en)
Inventor
‧韋納斯特羅姆
‧董
‧查曼
‧威特林
‧喬列特
‧克裡克
‧王
‧斯裡拉加萬
‧周
‧馬蒂勒
Original Assignee
瘧疾藥物投資公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瘧疾藥物投資公司 filed Critical 瘧疾藥物投資公司
Publication of HK1147092A1 publication Critical patent/HK1147092A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/02—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11101070.8A 2007-10-31 2011-02-01 二螺 -三氧雜環戊烷抗瘧藥 HK1147092A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/930,606 US8067620B2 (en) 2005-05-04 2007-10-31 Dispiro 1,2,4-trioxolane antimalarials
PCT/US2008/081579 WO2009058859A2 (en) 2007-10-31 2008-10-29 Dispiro 1,2,4-trioxolane antimalarials

Publications (1)

Publication Number Publication Date
HK1147092A1 true HK1147092A1 (zh) 2011-07-29

Family

ID=40228026

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11101070.8A HK1147092A1 (zh) 2007-10-31 2011-02-01 二螺 -三氧雜環戊烷抗瘧藥

Country Status (20)

Country Link
US (1) US8067620B2 (zh)
EP (1) EP2203457B1 (zh)
JP (1) JP5559057B2 (zh)
KR (1) KR101588468B1 (zh)
CN (1) CN101842377B (zh)
AU (1) AU2008318819C1 (zh)
BR (1) BRPI0818121B8 (zh)
CA (1) CA2702256C (zh)
CY (1) CY1115148T1 (zh)
DK (1) DK2203457T3 (zh)
ES (1) ES2466319T3 (zh)
HK (1) HK1147092A1 (zh)
HR (1) HRP20140435T1 (zh)
MX (1) MX2010004601A (zh)
PL (1) PL2203457T3 (zh)
PT (1) PT2203457E (zh)
RU (1) RU2493159C2 (zh)
SI (1) SI2203457T1 (zh)
UA (1) UA99742C2 (zh)
WO (1) WO2009058859A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
WO2012106190A1 (en) 2011-01-31 2012-08-09 Bristol-Myers Squibb Company C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
US20150141437A1 (en) * 2012-06-13 2015-05-21 Medizinische Universität Wien Amidophenoxypropanolamines
CA2937752C (en) 2014-02-14 2023-02-07 The Regents Of The University Of California Cyclic peroxides as prodrugs for selective delivery of agents
US20200377483A1 (en) 2016-10-13 2020-12-03 Mmv Medicines For Malaria Venture New anti-malarial agent
EP3309156A1 (en) 2016-10-13 2018-04-18 MMV Medicines for Malaria Venture New anti-malarial agents
WO2018213220A1 (en) * 2017-05-16 2018-11-22 The Johns Hopkins University Ozonides for treating or preventing virus infections
WO2019005977A1 (en) 2017-06-27 2019-01-03 The Regents Of The University Of California TRIOXOLANE AGENTS
CN110878069A (zh) * 2019-12-09 2020-03-13 南京杰运医药科技有限公司 一种4-吗琳基-2-乙基哌嗪的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621062A (en) 1966-10-25 1971-11-16 Sterling Drug Inc 2-(8-cyclohexyloctanoyl or 7-cyclohexylheptanoyl)-1-naphthol
US3673222A (en) 1969-11-26 1972-06-27 Sydney Archer 2-(8-cyclohexyloctyl or 7-cyclohexylheptyl)-1,4-naphthoquinone and process for preparation and use thereof
US3682991A (en) 1970-10-19 1972-08-08 Sterling Drug Inc 3,3,5-trimethylcyclohexyl-alkyl-carboxylic acids
US4978678A (en) * 1986-11-20 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 12-halogenated forskolin derivatives
US4916204A (en) 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4816478A (en) 1987-08-24 1989-03-28 Thornfeldt Carl R Treatment of acquired immunodeficiency syndrome
US5053342A (en) 1987-12-24 1991-10-01 Litmus Concepts, Inc. Fecal occult blood test reagents
US5559145A (en) 1988-06-01 1996-09-24 Oxaco S.A. 1,2,4-trioxane derivatives
US5270344A (en) 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
JP2867529B2 (ja) 1990-01-22 1999-03-08 三菱電機株式会社 投写型表示装置
US5216175A (en) 1990-03-23 1993-06-01 Sri International Antimalarial analogs of artemisinin
US5219880A (en) 1991-03-29 1993-06-15 Dermatologic Research Corporation Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
US5510356A (en) 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria
US5171676A (en) 1991-10-31 1992-12-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of introducing hydroxyl groups into artemisinin and its derivatives
US5430148A (en) 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
DE69310518T2 (de) 1992-07-28 1997-10-02 Procter & Gamble Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
US5721209A (en) 1995-02-03 1998-02-24 The Regents Of The University Of California Iron chelator and inhibitor of iron-mediated oxidant injury
US5780675A (en) 1995-04-28 1998-07-14 The University Of New Mexico Deoxygossylic compounds
US5578637A (en) 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
US5672624A (en) 1995-11-22 1997-09-30 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5817692A (en) 1995-11-22 1998-10-06 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5932591A (en) 1996-12-02 1999-08-03 Johns Hopkins University C3 substituted trioxanes useful as antiparasitic drugs
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US8067620B2 (en) 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
CN101272777B (zh) * 2005-05-18 2013-01-30 兰贝克赛实验室有限公司 螺和二螺1,2,4-三氧戊环抗疟药的稳定剂型

Also Published As

Publication number Publication date
MX2010004601A (es) 2010-05-27
RU2493159C2 (ru) 2013-09-20
BRPI0818121B8 (pt) 2021-05-25
BRPI0818121A2 (pt) 2015-11-17
AU2008318819B2 (en) 2013-11-21
CN101842377A (zh) 2010-09-22
WO2009058859A2 (en) 2009-05-07
JP2011502131A (ja) 2011-01-20
KR101588468B1 (ko) 2016-01-25
EP2203457A2 (en) 2010-07-07
JP5559057B2 (ja) 2014-07-23
UA99742C2 (en) 2012-09-25
RU2010121919A (ru) 2011-12-10
CA2702256C (en) 2017-09-26
CY1115148T1 (el) 2016-12-14
CA2702256A1 (en) 2009-05-07
HRP20140435T1 (hr) 2014-06-20
US8067620B2 (en) 2011-11-29
CN101842377B (zh) 2015-07-01
AU2008318819A1 (en) 2009-05-07
WO2009058859A3 (en) 2009-06-18
US20080125411A1 (en) 2008-05-29
AU2008318819C1 (en) 2014-04-24
EP2203457B1 (en) 2014-03-05
ES2466319T3 (es) 2014-06-17
BRPI0818121B1 (pt) 2020-12-08
SI2203457T1 (sl) 2014-06-30
PL2203457T3 (pl) 2014-08-29
DK2203457T3 (da) 2014-05-12
PT2203457E (pt) 2014-06-06
KR20100087199A (ko) 2010-08-03

Similar Documents

Publication Publication Date Title
IL201973A0 (en) 3,3-spiroindolinone derivatives
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
ZA201001797B (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
HK1147092A1 (zh) 二螺 -三氧雜環戊烷抗瘧藥
IL225694A0 (en) Compounds 6,5- dihydro-h1-pyridine-2-one
EP2136810A4 (en) NOVEL 1,8-NAPHTHYRIDINE COMPOUNDS
ZA201000428B (en) Desalination
SI2356123T1 (sl) Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
IL200863A0 (en) Novel uses
GB0820231D0 (en) Airbagmodul, airbagmodulanordung und befestigungsverfahren
EP2202231A4 (en) 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE
IL201444A0 (en) New 4, 8 - diphenyl - polyazanaphthalene derivatives
GB0707146D0 (en) The bealyboard
HK1162032A1 (zh) -三氟- -羥基丙基化合物
HK1161684A1 (zh) -二氫 - -吡啶- -酮化合物
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
GB0719111D0 (en) T.m.2
GB0711387D0 (en) The fincubator
GB0701309D0 (en) The easi-strutt
GB0701035D0 (en) .
GB0701036D0 (en) .
IL181852A0 (en) D.s-hom
GB0804523D0 (en) L.g.d
GB0720590D0 (en) T.m.3
GB0723127D0 (en) T.m.5

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231029